Smoking in spondyloarthritis: unravelling the complexities

SS Zhao, NJ Goodson, S Robertson, K Gaffney - Rheumatology, 2020 - academic.oup.com
Tobacco smoking is a major threat to health. There is no doubt about the need to promote
and support cessation at every opportunity. Smoking has a clear role in RA, but what …

Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis

SR Harrison, H Marzo-Ortega - Expert Review of Clinical …, 2021 - Taylor & Francis
Introduction Axial spondyloarthritis (axSpA) is an inflammatory arthritis which affects
primarily the entheses of the spine and sacroiliac joints with peripheral joint synovitis and …

[HTML][HTML] Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil

RA Toledo, FMF Grizzo, V Fernandes… - Advances in …, 2022 - SciELO Brasil
Background The aim of this study was to evaluate disease activity among patients with axial
spondyloarthritis (AS) treated with tumor necrosis factor inhibitors (TNFi) and/or nonsteroidal …

Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot study

SR Harrison, AN Burska, P Emery… - …, 2021 - academic.oup.com
Objective Ankylosing spondylitis (AS) is a chronic inflammatory arthritis primarily affecting
the spine and sacroiliac joints. TNF inhibitor (TNFi) drugs are recommended for patients not …

[PDF][PDF] Methods for systematic review and meta-analysis

SS Zhao, NJ Goodson, S Robertson, K Gaffney - researchgate.net
Data shown as mean and standard deviation (SD) unless otherwise indicated. Data in italics
were calculated from extracted data. n= number of individuals; SD, standard deviation; …